Day: July 23, 2024
NORTH LIBERTY, Iowa, July 23, 2024 (GLOBE NEWSWIRE) — Heartland Express, Inc. (Nasdaq: HTLD) announced today financial results for the three and six months ended June 30, 2024.
Three months ended June 30, 2024:Operating Revenue of $274.8 million,
Operating Income of $0.3 million,
Net Loss of $3.5 million,
Basic Loss per Share of $0.04,
Operating Ratio of 99.9% and 99.4% Non-GAAP Adjusted Operating Ratio(1),
Total Assets of $1.4 billion,
Stockholders’ Equity of $836.8 million.Six months ended June 30, 2024:Operating Revenue of $545.1 million,
Net Loss of $18.6 million,
Basic Loss per Share of $0.24,
Operating Ratio of 102.6% and 102.5% Non-GAAP Adjusted Operating Ratio(1).Heartland Express Chief Executive Officer Mike Gerdin commented on the quarterly operating results and ongoing initiatives of the Company, “Our...
ScottsMiracle-Gro Announces Timing of Third Quarter 2024 Financial Results and Webcast
Written by Customer Service on . Posted in Earnings Releases And Operating Results.
MARYSVILLE, Ohio, July 23, 2024 (GLOBE NEWSWIRE) — The Scotts Miracle-Gro Company (NYSE: SMG), the world’s leading marketer of branded consumer lawn and garden as well as indoor and hydroponic growing products, will release its third quarter financial results on Wednesday, July 31, 2024, prior to the opening of the U.S. financial markets. The Company will host a video presentation via webcast at 9:00 a.m. ET to discuss those results. The webcast will be followed by an audio question-and-answer session.
To watch the Company presentation and listen to the question-and-answer session, please register in advance at this webcast link. For those planning to participate in the question-and-answer session that follows the video presentation, please register for the webcast to view the presentation in addition to registering in advance...
Bioplastics Market to Surpass $56.36 Billion by 2031 | SkyQuest Technology
Written by Customer Service on . Posted in Mergers And Acquisitions.
Westford, USA, July 23, 2024 (GLOBE NEWSWIRE) — Global Bioplastics Market size was valued at USD 11.6 Billion in 2022 and is poised to grow from USD 13.83 Billion in 2023 to USD 56.36 Billion by 2031, growing at a CAGR of 19.20% during the forecast period (2024-2031).
Download a detailed overview:
https://www.skyquestt.com/sample-request/bioplastics-market
SkyQuest projects that the bioplastics market will attain a value of $56.36 Billion by 2031, with a CAGR of 19.20% over the forecast period (2024-2031). Bioplastic creation includes insects, seaweed, and mammals. Polymers made from biomass can take the place of traditional plastics in applications such as furniture, textiles, automobile parts, electrical components, and packaging.
The bioplastics market is driven by rise in demand for sustainable plastics by the packaging...
Companion Diagnostics Market to Surpass a CAGR of 11.4% | SkyQuest Technology
Written by Customer Service on . Posted in Mergers And Acquisitions.
Westford, USA, July 23, 2024 (GLOBE NEWSWIRE) — Global Companion Diagnostic Market size was valued at USD 6.62 Billion in 2022 and is poised to grow from USD 7.37 Billion in 2023 to USD 17.48 Billion by 2031, growing at a CAGR of 11.4% in the forecast period (2024-2031).
SkyQuest projects that the companion diagnostics market will attain a value of $17.48 Billion by 2031, with a CAGR of 11.4% over the forecast period (2024-2031). Companion diagnostics plays a major role in the safe and effective use of specific biological products or drugs, especially in the diagnosis and treatment of cancer. These assays are useful in adjusting treatment regimens according to the unique biomarker profiles found in each patient.
The companion diagnostics market has witnessed substantial growth. This is attributed to the trend toward precision...
Reborn Coffee Provides First Quarter 2024 Corporate Update and Financial Results
Written by Customer Service on . Posted in Public Companies.
Q12024 Revenue Increased 35% to $1.5 Million
Q1 2024 Gross Profit Increased 51% to $1.1 Million
BREA, Calif., July 23, 2024 (GLOBE NEWSWIRE) — Reborn Coffee Inc. (Nasdaq: REBN), (“Reborn”, or the “Company”), a California-based retailer of specialty coffee, has reported its financial and operational results for the first quarter ended March 31, 2024.
Key Financial and Operational HighlightsRevenue increased 35% to $1.5 million in Q1’24 from $1.1 million in Q1’23.
Ended Q1’24 with 11 open locations, with one location in development.
Company-operated store sales increased to $1.5 million, or 33%, in Q1’24, compared to the same period in 2023.
Company-operated store gross profit was $1.2 million in Q1’24, compared to $0.7 million for the same period in 2023.Q1 2024 and Subsequent EventsSigned Memorandum...
APA Corporation Publishes 2024 Sustainability Report
Written by Customer Service on . Posted in Public Companies.
HOUSTON, July 23, 2024 (GLOBE NEWSWIRE) — APA Corporation (Nasdaq: APA) today published its 2024 Sustainability Report. Highlights from the report include the achievement of key Environmental, Social and Governance (ESG) goals in 2023 and progression of the company’s sustainability initiatives and emissions reduction efforts. The full report is available on APA’s website.
“Throughout the past year, APA has demonstrated consistent progress and excellent performance across our sustainability focus areas while responsibly producing oil and natural gas,” said John J. Christmann IV, APA CEO. “Energy remains the bedrock of human progress, and our talented, global workforce is unwavering in its commitment to making APA a safety-first, responsible oil and natural gas company. This solid foundation has strategically positioned our company...
Announces Closing of $5.0 Million Registered Direct Offering and Concurrent Private Placement
Written by Customer Service on . Posted in Public Companies.
July 23, 2024
Biodexa Pharmaceuticals PLC
Announces Closing of $5.0 Million Registered Direct Offering and Concurrent Private Placement
Biodexa Pharmaceuticals PLC (“Biodexa” or the “Company”) (Nasdaq: BDRX), an acquisition-focused clinical stage biopharmaceutical company developing a pipeline of innovative products for the treatment of diseases with unmet medical needs, today announced the closing of its previously announced registered direct offering of an aggregate of (i) 5,050,808 American Depositary Shares (the “Depositary Shares”) (each Depositary Share representing 400 of the Company’s ordinary shares, nominal value £0.001 per share) and (ii) 278,975 pre-funded warrants exercisable for Depositary Shares, at a purchase price of $0.94 per Depositary Share (or $0.9399 per pre-funded warrant).
The net proceeds from the offering were...
Climb Global Solutions Sets Second Quarter 2024 Conference Call for August 7, 2024 at 8:30 a.m. ET
Written by Customer Service on . Posted in Public Companies.
EATONTOWN, N.J., July 23, 2024 (GLOBE NEWSWIRE) — Climb Global Solutions, Inc. (NASDAQ:CLMB) (“Climb” or the “Company”), a value-added global IT channel company providing unique sales and distribution solutions for innovative technology vendors, will host a conference call on Wednesday, August 7, 2024 at 8:30 a.m. Eastern time to discuss its financial results for the second quarter ended June 30, 2024. The Company’s results will be reported in a press release prior to the call.
Climb’s management will host the conference call, followed by a question-and-answer period. Interested parties may submit questions to the Company prior to the call by emailing CLMB@elevate-ir.com.
Date: Wednesday, August 7, 2024Time: 8:30 a.m. Eastern timeToll-free dial-in number: (800) 245-3047International dial-in number: (203) 518-9765Conference ID:...
Hudson Technologies to Host Conference Call to Discuss Second Quarter 2024 Results
Written by Customer Service on . Posted in Public Companies.
WOODCLIFF LAKE, N.J., July 23, 2024 (GLOBE NEWSWIRE) — Hudson Technologies, Inc. (NASDAQ: HDSN) will host a conference call and webcast on Tuesday, August 6, 2024 at 5:00 p.m. Eastern Time to discuss the Company’s second quarter 2024 results.
To access the live webcast, log onto the Hudson Technologies website at www.hudsontech.com, and click on “Events”.
To participate in the call by phone, dial (877) 545-0523 approximately five minutes prior to the scheduled start time. International callers please dial (973) 528-0016. Callers should use entry code: 384150.
A replay of the teleconference will be available until September 5, 2024 and may be accessed by dialing (877) 481-4010. International callers may dial (919) 882-2331. Callers should use conference ID: 50910.
About Hudson Technologies
Hudson Technologies, Inc. is a leading...
Milestone Scientific Announces Medicare Price Assignment for the CompuFlo® Epidural System in Texas, Pennsylvania, New Jersey, Maryland, Colorado, Oklahoma, Louisiana, Arkansas, Mississippi, New Mexico, District of Columbia, and Delaware
Written by Customer Service on . Posted in Public Companies.
ROSELAND, N.J., July 23, 2024 (GLOBE NEWSWIRE) — Milestone Scientific Inc. (NYSE: MLSS), a leading developer of computerized drug delivery instruments that provide painless and precise injections, today announced that Novitas Solutions, Inc. (Novitas), a Jurisdictional Medicare Administrative Contractor (JMAC), has granted a Medicare Part B Physician payment rate for the Company’s CompuFlo® Epidural System under the American Medical Association’s (AMA) technology-specific Category III CPT® code CPT0777T (real-time pressure-sensing epidural guidance system when used in conjunction with a primary ESI procedure).
This new price assignment applies to two Medicare regions: Jurisdiction L (JL) and Jurisdiction H (JH). JL includes Delaware, District of Columbia, Maryland, New Jersey, and Pennsylvania. JH includes Arkansas, Colorado, Louisiana,...